Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edoardo Alesse

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Advances in Experimental Medicine and Biology|June 25, 2020
Leptin in Tumor MicroenvironmentAdriano Angelucci, Letizia Clementi, Edoardo Alesse
Expert Review of Proteomics|June 20, 2013
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancersAlessandra Tessitore, Francesca Zazzeroni, Edoardo Alesse
The Journal of Biological Chemistry|May 5, 2004
Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damageAlessandra Ianari, Rita Gallo, Marzia Palma, et al.
Journal of Biomedicine & Biotechnology|April 14, 2012
Targeting costimulatory molecules to improve antitumor immunityDaria Capece, Daniela Verzella, Mariafausta Fischietti, et al.
World Journal of Clinical Oncology|August 13, 2014
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsNadia Rucci, Patrizia Sanità, Simona Delle Monache, et al.
Seminars in Cell & Developmental Biology|August 7, 2017
Cancer secretome and inflammation: The bright and the dark sides of NF-κBDaria Capece, Daniela Verzella, Alessandra Tessitore, et al.
Seminars in Cell & Developmental Biology|May 28, 2019
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyondDaria Capece, Daniela Verzella, Barbara Di Francesco, et al.
Cell Cycle (Georgetown, Tex.)|October 7, 2004
Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathwayEnrico De Smaele, Lucia Di Marcotullio, Elisabetta Ferretti, et al.
Critical Reviews in Oncology/Hematology|December 3, 2014
The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?Gemma Bruera, Katia Cannita, Alessandra Tessitore, et al.
Anticancer Research|August 6, 2005
Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapyFrancesco Recchia, Gaetano Saggio, Alisia Cesta, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|June 25, 2020
Leptin in Tumor MicroenvironmentAdriano Angelucci, Letizia Clementi, Edoardo Alesse
Expert Review of Proteomics|June 20, 2013
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancersAlessandra Tessitore, Francesca Zazzeroni, Edoardo Alesse
The Journal of Biological Chemistry|May 5, 2004
Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damageAlessandra Ianari, Rita Gallo, Marzia Palma, et al.
Journal of Biomedicine & Biotechnology|April 14, 2012
Targeting costimulatory molecules to improve antitumor immunityDaria Capece, Daniela Verzella, Mariafausta Fischietti, et al.
World Journal of Clinical Oncology|August 13, 2014
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsNadia Rucci, Patrizia Sanità, Simona Delle Monache, et al.
Seminars in Cell & Developmental Biology|August 7, 2017
Cancer secretome and inflammation: The bright and the dark sides of NF-κBDaria Capece, Daniela Verzella, Alessandra Tessitore, et al.
Seminars in Cell & Developmental Biology|May 28, 2019
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyondDaria Capece, Daniela Verzella, Barbara Di Francesco, et al.
Cell Cycle (Georgetown, Tex.)|October 7, 2004
Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathwayEnrico De Smaele, Lucia Di Marcotullio, Elisabetta Ferretti, et al.
Critical Reviews in Oncology/Hematology|December 3, 2014
The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?Gemma Bruera, Katia Cannita, Alessandra Tessitore, et al.
Anticancer Research|August 6, 2005
Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapyFrancesco Recchia, Gaetano Saggio, Alisia Cesta, et al.
Pageof 8